Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Alto Neuroscience
About
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Artificial Intelligence,Biopharma,Biotechnology,Health Care,Neuroscience
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develop highly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 25, 2022 | Series B | $35M | 2 | — | — | Detail |
| May 24, 2021 | Series B | — | 1 | — | — | Detail |
| May 3, 2021 | Series A | $32M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Korify Capital
|
— | Series B |
Gaingels
|
— | Series B |
NJF Capital
|
— | Series B |
